Combinational Immunotherapy
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14776 | Camrelizumab | 1 | Recruiting | 1 |
| DB09078 | Lenvatinib | 2 | Completed | 1 |
| DB09037 | Pembrolizumab | 2 | Completed | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14776 | Camrelizumab | 1 | Recruiting | 1 |
| DB09078 | Lenvatinib | 2 | Completed | 1 |
| DB09037 | Pembrolizumab | 2 | Completed | 1 |